Related Experiment Video

Updated: Jun 13, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis

Sante D Pierdomenico1, Franco Cuccurullo

  • 1Dipartimento di Medicina e Scienze dell'Invecchiamento, Università "Gabriele d'Annunzio", Chieti, Italy. pierdomenico@unich.it

American Journal of Hypertension
|April 24, 2010
PubMed

Insights

Regression of left ventricular hypertrophy (LVH) in hypertension patients significantly reduces cardiovascular events. This finding highlights the importance of monitoring and managing LVH for better patient outcomes.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Preventive Medicine

Background:

  • The prognostic significance of left ventricular hypertrophy (LVH) regression in hypertensive individuals remains unclear.
  • Echocardiographic assessment of LVH is crucial for cardiovascular risk stratification.

Purpose of the Study:

  • To conduct an updated meta-analysis on the impact of LVH regression on cardiovascular events in hypertensive patients.
  • To clarify the prognostic value of LVH regression in hypertension.

Main Methods:

  • Systematic search for studies on echocardiographic LVH regression and prognosis in hypertension.
  • Inclusion of studies comparing patients with or without LVH regression.
  • Calculation of overall effect size using adjusted hazard ratios (HR).

Main Results:

  • Analysis of 5 studies with 3,149 patients; 2,449 included in meta-analysis.
  • LVH regression was associated with a 46% reduction in cardiovascular events (HR 0.54, 95% CI 0.35-0.84, P=0.007).
  • Heterogeneity observed; potential for lower benefit in Japanese ethnicity and those with comorbid conditions.

Conclusions:

  • Regression of echocardiographic LVH in hypertension is linked to reduced cardiovascular events.
  • Further research is needed to determine benefits across diverse patient and ethnic groups.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...